Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Cvetic, Alaina
DISSOLVE II, NCT04596540: A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy II	Completed	3	153	US, RoW	SEL-212 low-dose, SEL-212 high-dose, Placebo	Swedish Orphan Biovitrum	Chronic Gout	01/23	01/23